Using splicing-sensitive microarrays and RNA sequencing, the abundance of both KRAS splice variants was investigated in samples from patients with microsatellite stable (MSS) colorectal cancer (CRC) (Eilertsen et al., 2019). The gene discussed is KRAS; the disease is colorectal carcinoma.